These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33124916)

  • 1. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM; Bargnoux AS; Montagnon V; Kuster N; Badiou S; Cristol JP
    Scand J Clin Lab Invest; 2020 Nov; 80(7):541-545. PubMed ID: 33124916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay.
    Dupuy AM; Né M; Bargnoux AS; Badiou S; Cristol JP
    Clin Biochem; 2017 Mar; 50(4-5):248-250. PubMed ID: 27838408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Demonte D; Faggian D; Plebani M
    Diagnostics (Basel); 2020 Feb; 10(3):. PubMed ID: 32111028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O; Salvagno GL; Gelati M; Lippi G
    Pract Lab Med; 2016 Dec; 6():8-13. PubMed ID: 28856208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin.
    Dupuy AM; Bargnoux AS; Larcher R; Merindol A; Masetto T; Badiou S; Cristol JP
    Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32646054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performances of a novel point-of-care procalcitonin assay.
    Dupuy AM; Bargnoux AS; Andreeva A; Zins C; Kuster N; Badiou S; Cristol JP
    Pract Lab Med; 2020 Jan; 18():e00145. PubMed ID: 31720356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and clinical performance of the Advansure i3 procalcitonin assay.
    Heo W; Park HD
    Scand J Clin Lab Invest; 2021 Nov; 81(7):546-551. PubMed ID: 34601986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W; Krassler J; Zingler C; Pertschy A; Hentschel J; Gerhards-Reich C; Mack M; Demant T
    Clin Lab; 2003; 49(7-8):319-27. PubMed ID: 12908732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Lo Cascio C; Demonte D; Faggian D; Plebani M
    Clin Chem Lab Med; 2019 Dec; 58(1):77-84. PubMed ID: 31539351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor.
    Ceriotti F; Marino I; Motta A; Carobene A
    Clin Chem Lab Med; 2017 Nov; 56(1):162-169. PubMed ID: 28809746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A; Rotaru I; Beaudeux JL; Hennequin C
    Ann Biol Clin (Paris); 2018 Jun; 76(3):308-312. PubMed ID: 29622524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Procalcitonin Assays on KRYPTOR and LIAISON
    Dipalo M; Gnocchi C; Avanzini P; Musa R; Di Pietro M; Aloe R
    Diagnostics (Basel); 2019 Aug; 9(3):. PubMed ID: 31398868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M; Guido L; Micca G; Pittalis S; Locatelli M; Motta A; Bianchi V; Callegari T; Aloe R; Da Rin G; Lippi G
    Pract Lab Med; 2015 Aug; 2():22-28. PubMed ID: 28932801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB; Hayden J; Colby JM
    Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical Evaluation of Point-of-Care Finecare™ Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys
    Mazlan MZ; Wan Azman WN; Yaacob NM; Koon TS; Yahya NK
    Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.
    Walker C; Shuster A; Weber C; Gebhardt K; Scheidegger M; Swartzwelder J; Williams J; Li J
    Ann Clin Lab Sci; 2021 Mar; 51(2):241-244. PubMed ID: 33941564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance of Three Automated Procalcitonin Immunoassays at Medical Decision Points.
    Cho HW; Kim SH; Cho Y; Jeong SH; Lee SG
    Ann Lab Med; 2021 Jul; 41(4):419-423. PubMed ID: 33536362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.
    Wang G; Wan Y; Lin G; Li Z; Dong Z; Liu T
    J Immunol Methods; 2020; 484-485():112829. PubMed ID: 32673618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new sensitive automated assay for procalcitonin detection: LIAISON
    Fortunato A
    Pract Lab Med; 2016 Dec; 6():1-7. PubMed ID: 28856207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.